We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+12.46%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.24%
AUM
$17B
AUM Growth
+$1.34B
(+8.6%)
Cap. Flow
-$377M
Cap. Flow
% of AUM
-2.22%
Top 10 Holdings %
Top 10 Hldgs %
15.59%
Holding
389
New
43
Increased
82
Reduced
143
Closed
65
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$204M |
| 2 |
AbbVie
ABBV
|
+$141M |
| 3 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$130M |
| 4 |
Caterpillar
CAT
|
+$125M |
| 5 |
Johnson Controls International
JCI
|
+$90.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VPHM
VIROPHARMA INC
VPHM
|
+$188M |
| 2 |
Merck
MRK
|
+$155M |
| 3 |
Apple
AAPL
|
+$155M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$131M |
| 5 |
Bread Financial
BFH
|
+$96.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.01% |
| 2 | Industrials | 15.63% |
| 3 | Consumer Discretionary | 14.7% |
| 4 | Technology | 8.94% |
| 5 | Communication Services | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CEB
126
DELISTED
CEB Inc.
CEB
| $43.2M | 0.25% |
558,508
-11,725
| -2% | -$862K |
|
127
Mohawk Industries
MHK
$9.25B
| $43.1M | 0.25% |
289,705
-8,720
| -3% | -$1.19M |
|
128
Vulcan Materials
VMC
$36.9B
| $42.9M | 0.25% |
722,515
+199,755
| +38% | +$11M |
|
|
MASI
129
DELISTED
Masimo
MASI
| $41.2M | 0.24% |
1,410,513
-70,845
| -5% | -$1.98M |
|
|
WBC
130
DELISTED
WABCO HOLDINGS INC.
WBC
| $41M | 0.24% |
+439,020
| New | +$38.5M |
|
|
TMH
131
DELISTED
Team Health Holdings Inc
TMH
| $40.9M | 0.24% |
898,253
-52,970
| -6% | -$2.36M |
|
|
MDR
132
DELISTED
McDermott International
MDR
| $40.7M | 0.24% |
1,482,188
-68,004
| -4% | -$1.59M |
|
|
JNPR
133
DELISTED
Juniper Networks
JNPR
| $40.7M | 0.24% |
1,801,340
+369,440
| +26% | +$7.49M |
|
|
HAR
134
DELISTED
Harman International Industries
HAR
| $40.5M | 0.24% |
494,624
-140,828
| -22% | -$10.9M |
|
|
INFA
135
DELISTED
INFORMATICA CORP
INFA
| $40.5M | 0.24% |
975,260
-42,190
| -4% | -$1.64M |
|
|
GWR
136
DELISTED
Genesee & Wyoming Inc.
GWR
| $40.4M | 0.24% |
+420,615
| New | +$40.5M |
|
|
SGI
137
Somnigroup International
SGI
$14B
| $40.1M | 0.24% |
2,974,880
-563,120
| -16% | -$6.47M |
|
|
DNR
138
DELISTED
Denbury Resources, Inc.
DNR
| $39.9M | 0.23% |
2,428,678
-1,581,720
| -39% | -$27.9M |
|
139
Robert Half
RHI
$4.19B
| $39.9M | 0.23% |
949,150
+417,960
| +79% | +$16.5M |
|
|
HMA
140
DELISTED
HEALTH MGMT ASSOC INC CL-A
HMA
| $39.3M | 0.23% |
2,998,485
-173,220
| -5% | -$2.24M |
|
141
Church & Dwight Co
CHD
$24.4B
| $38.6M | 0.23% |
1,165,610
+279,710
| +32% | +$9.01M |
|
142
Interface
TILE
$2.01B
| $38.5M | 0.23% |
1,754,915
+14,031
| +0.8% | +$283K |
|
|
WCN
143
Waste Connections
WCN
$41.7B
| $38M | 0.22% |
1,307,271
-906,315
| -41% | -$26.5M |
|
|
CAA
144
DELISTED
CalAtlantic Group, Inc.
CAA
| $37.6M | 0.22% |
831,212
+153,892
| +23% | +$6.13M |
|
145
Allison Transmission
ALSN
$10.2B
| $37.1M | 0.22% |
1,345,475
+35,800
| +3% | +$926K |
|
|
CNQR
146
DELISTED
CONCUR TECHNOLOGIES INC
CNQR
| $36.7M | 0.22% |
356,030
-15,780
| -4% | -$1.6M |
|
147
Aon
AON
$75.7B
| $36M | 0.21% |
+429,030
| New | +$34M |
|
|
CYBX
148
DELISTED
CYBERONICS INC
CYBX
| $35.6M | 0.21% |
544,600
-27,240
| -5% | -$1.65M |
|
149
Donaldson
DCI
$11.4B
| $35.5M | 0.21% |
+816,488
| New | +$33.3M |
|
|
P
150
DELISTED
Pandora Media Inc
P
| $35.3M | 0.21% |
1,327,340
-527,865
| -28% | -$14.5M |
|
Similar funds
OAG
JG
CHP
SC
Westfield Capital Management's Q4 2013 Portfolio in Review
As of Q4 2013, Westfield Capital Management held 389 positions worth $17B, up 8.6% from $15.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Westfield Capital Management's Q4 2013 filing shows 43 new, 82 increased, 143 reduced and 65 closed positions. Its largest new stake was Teva Pharmaceuticals: 5,174,039 shares worth $207M. The largest sale was VIROPHARMA INC, an estimated $188M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.
- Westfield Capital Management's largest Q4 2013 buy was Teva Pharmaceuticals: 5,174,039 shares worth $207M.
- Westfield Capital Management added most to AbbVie in Q4 2013, an estimated $141M increase.
- Westfield Capital Management's biggest Q4 2013 reduction was VIROPHARMA INC, cutting an estimated $188M.
- Westfield Capital Management fully exited Citrix Systems Inc in Q4 2013, selling an estimated $131M.
- Westfield Capital Management's ten largest holdings make up 16% of its $17B portfolio in Q4 2013.
- Westfield Capital Management opened 43 new positions and closed 65 in Q4 2013.
- Westfield Capital Management's portfolio value rose 8.6% quarter-over-quarter to $17B.
Based on Westfield Capital Management's 13F filing for Q4 2013, filed 7 Feb 2014.